BROLUCIZUMAB
UNII XSZ53G39H5

Substance Identification & Data

This profile provides standardized clinical and technical data for Brolucizumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) XSZ53G39H5.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1531589-13-5 and the RxNorm Concept ID (RxCUI) 2204915. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

XSZ53G39H5

CAS Registry Number

1531589-13-5

RxNorm Concept ID

2204915

Detailed Substance Profile

Preferred Name

BROLUCIZUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

XSZ53G39H5

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C169818

National Cancer Institute reference terminology for clinical and research data.

INN ID

10053

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

DE-66

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Brolucizumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.